SinoPep: difference between revisions
Diff·revision 21 → 22·09:48, 18 Dec 2025
Difference between revision 21 and revision 22 of SinoPep. 17 lines changed; the page grew by 2,128 bytes.
| Revision 21 — 16:22, 5 Dec 2025 SecondarySrc_Seb (talk) rm the discount code added by an anonymous editor 13,439 bytes +271 | Revision 22 — 09:48, 18 Dec 2025 UnitsUrsula (talk) clarify that a registered business scope is a licensing fact, not a quality assurance 15,567 bytes +2,128 | ||
|---|---|---|---|
| 75 | Material described here is labelled [[Research use only|for research use only]] and is '''not approved for human use''' in any jurisdiction. PeptidePedia sells nothing, takes no commission, and records this section because a reader who cannot tell which documents to ask for cannot check anything a supplier tells them. | 75 | Material described here is labelled [[Research use only|for research use only]] and is '''not approved for human use''' in any jurisdiction. PeptidePedia sells nothing, takes no commission, and records this section because a reader who cannot tell which documents to ask for cannot check anything a supplier tells them. |
| 76 | 76 | ||
| + | 77 | [https://sinopep.net/ Go to the SinoPep catalogue →] | |
| + | 78 | ||
| 77 | == Reception == | 79 | == Reception == |
| 78 | The PeptidePedia tally records 806 self-reported submissions concerning SinoPep to July 2026. The theme that recurs most often is documentary and specific: submitters describe [[Counterion|counter-ion]] content reported as a quantity with units on the certificate as issued rather than supplied on request, alongside water by [[Karl Fischer titration|Karl Fischer titration]] and [[Peptide content|content]].{{r|tally}} A second recurring theme is agreement between a reorder and an original order of the same line determined on the same stated method.{{r|tally}} A third theme is recorded because omitting it would curate the entry: a delay of about three working days in obtaining a written quotation for a sequence outside the catalogue, against same-day acknowledgement on catalogue enquiries.{{r|tally}} The tally is self-selected and measures reception rather than quality, and it is not comparable with the figure any other community publishes for the same organisation.{{r|tally}} | 80 | The PeptidePedia tally records 806 self-reported submissions concerning SinoPep to July 2026. The theme that recurs most often is documentary and specific: submitters describe [[Counterion|counter-ion]] content reported as a quantity with units on the certificate as issued rather than supplied on request, alongside water by [[Karl Fischer titration|Karl Fischer titration]] and [[Peptide content|content]].{{r|tally}} A second recurring theme is agreement between a reorder and an original order of the same line determined on the same stated method.{{r|tally}} A third theme is recorded because omitting it would curate the entry: a delay of about three working days in obtaining a written quotation for a sequence outside the catalogue, against same-day acknowledgement on catalogue enquiries.{{r|tally}} The tally is self-selected and measures reception rather than quality, and it is not comparable with the figure any other community publishes for the same organisation.{{r|tally}} |
| 79 | 81 | ||
| + | 82 | The tally is self-selected. It measures who chose to submit, which is not the same as what the catalogue does, and no figure derived from it should be read as a rate.{{r|tally}} | |
| + | 83 | ||
| + | 84 | === How this tally should be read === | |
| + | 85 | The reception figure above is a count of self-reported submissions to PeptidePedia, not a score: this wiki publishes none, and the figure says how many people wrote in rather than how good anything is. It is '''weak evidence''' and is subject to three limitations that apply to every such figure on this wiki: | |
| + | 86 | ||
| + | 87 | * '''Self-selection.''' People who submit are not a sample of purchasers. Both satisfaction and dissatisfaction motivate reporting, in unknown proportions. | |
| + | 88 | * '''It measures reception, not quality.''' Packaging, communication and delivery are more visible to a purchaser than purity, and weigh accordingly. | |
| + | 89 | * '''It is not comparable across communities.''' Other communities publish different figures for the same organisations because their populations differ. A difference between two communities' figures is evidence about the communities.{{r|tally}} | |
| + | 90 | ||
| + | 91 | == Regulatory position and legal status == | |
| + | 92 | The organisation is a commercial entity registered in the People's Republic of China. Nothing in the available record indicates a manufacturing authorisation, marketing authorisation or pharmacopoeial registration in any jurisdiction, and none should be inferred from a registered business scope, which is a licensing fact and not a quality assurance.{{r|registry}} | |
| + | 93 | ||
| + | 94 | Material labelled [[Research use only|for research use only]] is outside the regulatory framework that governs medicines. Its identity, purity, sterility and [[Bacterial endotoxin test|endotoxin]] content are not assured by any regulator, and a [[Certificate of analysis|certificate of analysis]] issued by a supplier is a claim by that supplier rather than an independent finding.{{r|ruo,usp1503}} | |
| + | 95 | ||
| 80 | == References == | 96 | == References == |
| 81 | {{reflist}} | 97 | {{reflist}} |
| ⋮ | ⋮ | ||
| 84 | <ref name="reports">Independent test reports submitted to PeptidePedia by purchasers, 2024–2026. Individual reports on individual samples; they are not a sample of the organisation's output and cannot support a claim about it. See [[Blind sampling]].</ref> | 100 | <ref name="reports">Independent test reports submitted to PeptidePedia by purchasers, 2024–2026. Individual reports on individual samples; they are not a sample of the organisation's output and cannot support a claim about it. See [[Blind sampling]].</ref> |
| 85 | <ref name="tally">PeptidePedia reception tally (self-reported submissions; '''weak evidence''' — see [[Project:Sourcing guidelines]]). Self-selected sample; period and count stated at each point of use.</ref> | 101 | <ref name="tally">PeptidePedia reception tally (self-reported submissions; '''weak evidence''' — see [[Project:Sourcing guidelines]]). Self-selected sample; period and count stated at each point of use.</ref> |
| + | 102 | <ref name="usp1503">United States Pharmacopeia, General Chapter <1503>, "Quality Attributes of Synthetic Peptide Drug Substances" (informational). USP–NF, current revision.</ref> | |
| 86 | <ref name="ruo">Research-use-only labelling practice; see [[Research use only]] for the legal and commercial function of the phrase.</ref> | 103 | <ref name="ruo">Research-use-only labelling practice; see [[Research use only]] for the legal and commercial function of the phrase.</ref> |
| 87 | 104 |